nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—ovarian cancer—polycystic ovary syndrome	0.542	1	CtDrD
Epirubicin—TOP2A—polycystic ovary syndrome	0.308	1	CbGaD
Epirubicin—CHD1—adrenal cortex—polycystic ovary syndrome	0.00212	0.0384	CbGeAlD
Epirubicin—CHD1—endometrium—polycystic ovary syndrome	0.00189	0.0343	CbGeAlD
Epirubicin—CHD1—uterus—polycystic ovary syndrome	0.00174	0.0316	CbGeAlD
Epirubicin—CHD1—pituitary gland—polycystic ovary syndrome	0.00171	0.031	CbGeAlD
Epirubicin—CHD1—adipose tissue—polycystic ovary syndrome	0.0017	0.0309	CbGeAlD
Epirubicin—CHD1—adrenal gland—polycystic ovary syndrome	0.00153	0.0277	CbGeAlD
Epirubicin—AURKA—endometrium—polycystic ovary syndrome	0.00152	0.0276	CbGeAlD
Epirubicin—Tooth abscess—Metformin—polycystic ovary syndrome	0.00145	0.0505	CcSEcCtD
Epirubicin—DHCR7—adrenal cortex—polycystic ovary syndrome	0.00143	0.0259	CbGeAlD
Epirubicin—CHD1—female gonad—polycystic ovary syndrome	0.00143	0.0258	CbGeAlD
Epirubicin—CHD1—vagina—polycystic ovary syndrome	0.00142	0.0257	CbGeAlD
Epirubicin—AURKA—uterus—polycystic ovary syndrome	0.0014	0.0255	CbGeAlD
Epirubicin—Valrubicin—TOP2A—polycystic ovary syndrome	0.0014	0.36	CrCbGaD
Epirubicin—AURKA—pituitary gland—polycystic ovary syndrome	0.00138	0.025	CbGeAlD
Epirubicin—CHD1—endocrine gland—polycystic ovary syndrome	0.00133	0.024	CbGeAlD
Epirubicin—YWHAG—adrenal cortex—polycystic ovary syndrome	0.00131	0.0238	CbGeAlD
Epirubicin—AURKA—adrenal gland—polycystic ovary syndrome	0.00123	0.0223	CbGeAlD
Epirubicin—YWHAG—endometrium—polycystic ovary syndrome	0.00117	0.0212	CbGeAlD
Epirubicin—DHCR7—pituitary gland—polycystic ovary syndrome	0.00115	0.0209	CbGeAlD
Epirubicin—DHCR7—adipose tissue—polycystic ovary syndrome	0.00115	0.0208	CbGeAlD
Epirubicin—AURKA—female gonad—polycystic ovary syndrome	0.00115	0.0208	CbGeAlD
Epirubicin—AURKA—vagina—polycystic ovary syndrome	0.00114	0.0207	CbGeAlD
Epirubicin—Body temperature decreased—Metformin—polycystic ovary syndrome	0.00108	0.0376	CcSEcCtD
Epirubicin—Hypothermia—Metformin—polycystic ovary syndrome	0.00108	0.0376	CcSEcCtD
Epirubicin—YWHAG—uterus—polycystic ovary syndrome	0.00108	0.0195	CbGeAlD
Epirubicin—AURKA—endocrine gland—polycystic ovary syndrome	0.00107	0.0194	CbGeAlD
Epirubicin—YWHAG—pituitary gland—polycystic ovary syndrome	0.00106	0.0192	CbGeAlD
Epirubicin—YWHAG—adipose tissue—polycystic ovary syndrome	0.00105	0.0191	CbGeAlD
Epirubicin—DHCR7—adrenal gland—polycystic ovary syndrome	0.00103	0.0187	CbGeAlD
Epirubicin—PLA2G4A—adrenal cortex—polycystic ovary syndrome	0.000977	0.0177	CbGeAlD
Epirubicin—DHCR7—female gonad—polycystic ovary syndrome	0.000961	0.0174	CbGeAlD
Epirubicin—DHCR7—vagina—polycystic ovary syndrome	0.000955	0.0173	CbGeAlD
Epirubicin—YWHAG—adrenal gland—polycystic ovary syndrome	0.000946	0.0171	CbGeAlD
Epirubicin—Nail disorder—Metformin—polycystic ovary syndrome	0.000933	0.0325	CcSEcCtD
Epirubicin—DHCR7—endocrine gland—polycystic ovary syndrome	0.000894	0.0162	CbGeAlD
Epirubicin—YWHAG—female gonad—polycystic ovary syndrome	0.000882	0.016	CbGeAlD
Epirubicin—YWHAG—vagina—polycystic ovary syndrome	0.000877	0.0159	CbGeAlD
Epirubicin—PLA2G4A—endometrium—polycystic ovary syndrome	0.000873	0.0158	CbGeAlD
Epirubicin—TOP2A—endometrium—polycystic ovary syndrome	0.000829	0.015	CbGeAlD
Epirubicin—YWHAG—endocrine gland—polycystic ovary syndrome	0.00082	0.0149	CbGeAlD
Epirubicin—Idarubicin—TOP2A—polycystic ovary syndrome	0.000804	0.207	CrCbGaD
Epirubicin—PLA2G4A—pituitary gland—polycystic ovary syndrome	0.00079	0.0143	CbGeAlD
Epirubicin—PLA2G4A—adipose tissue—polycystic ovary syndrome	0.000787	0.0143	CbGeAlD
Epirubicin—Fungal infection—Metformin—polycystic ovary syndrome	0.000784	0.0273	CcSEcCtD
Epirubicin—TOP2A—uterus—polycystic ovary syndrome	0.000764	0.0139	CbGeAlD
Epirubicin—TOP2A—adipose tissue—polycystic ovary syndrome	0.000747	0.0135	CbGeAlD
Epirubicin—Rigors—Metformin—polycystic ovary syndrome	0.000741	0.0259	CcSEcCtD
Epirubicin—UGT2B7—endocrine gland—polycystic ovary syndrome	0.000741	0.0134	CbGeAlD
Epirubicin—Blood disorder—Metformin—polycystic ovary syndrome	0.000725	0.0253	CcSEcCtD
Epirubicin—PLA2G4A—adrenal gland—polycystic ovary syndrome	0.000706	0.0128	CbGeAlD
Epirubicin—TOP2A—adrenal gland—polycystic ovary syndrome	0.00067	0.0122	CbGeAlD
Epirubicin—Doxorubicin—AKR1C3—polycystic ovary syndrome	0.000668	0.172	CrCbGaD
Epirubicin—PLA2G4A—female gonad—polycystic ovary syndrome	0.000658	0.0119	CbGeAlD
Epirubicin—PLA2G4A—vagina—polycystic ovary syndrome	0.000654	0.0119	CbGeAlD
Epirubicin—TOP2A—female gonad—polycystic ovary syndrome	0.000625	0.0113	CbGeAlD
Epirubicin—TOP2A—vagina—polycystic ovary syndrome	0.000621	0.0113	CbGeAlD
Epirubicin—PLA2G4A—endocrine gland—polycystic ovary syndrome	0.000612	0.0111	CbGeAlD
Epirubicin—Neuropathy—Metformin—polycystic ovary syndrome	0.000568	0.0198	CcSEcCtD
Epirubicin—ABCC1—adrenal cortex—polycystic ovary syndrome	0.000559	0.0101	CbGeAlD
Epirubicin—ABCC1—endometrium—polycystic ovary syndrome	0.000499	0.00905	CbGeAlD
Epirubicin—Renal impairment—Metformin—polycystic ovary syndrome	0.000462	0.0161	CcSEcCtD
Epirubicin—ABCC1—uterus—polycystic ovary syndrome	0.00046	0.00834	CbGeAlD
Epirubicin—ABCC1—pituitary gland—polycystic ovary syndrome	0.000452	0.00819	CbGeAlD
Epirubicin—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00045	0.0157	CcSEcCtD
Epirubicin—ABCC1—adipose tissue—polycystic ovary syndrome	0.00045	0.00816	CbGeAlD
Epirubicin—Lethargy—Metformin—polycystic ovary syndrome	0.000448	0.0156	CcSEcCtD
Epirubicin—Pain in extremity—Metformin—polycystic ovary syndrome	0.000439	0.0153	CcSEcCtD
Epirubicin—Migraine—Metformin—polycystic ovary syndrome	0.000432	0.0151	CcSEcCtD
Epirubicin—Daunorubicin—TOP2A—polycystic ovary syndrome	0.000431	0.111	CrCbGaD
Epirubicin—Dehydration—Metformin—polycystic ovary syndrome	0.000409	0.0142	CcSEcCtD
Epirubicin—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.000406	0.0141	CcSEcCtD
Epirubicin—ABCC1—adrenal gland—polycystic ovary syndrome	0.000404	0.00732	CbGeAlD
Epirubicin—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.000401	0.014	CcSEcCtD
Epirubicin—Breast disorder—Metformin—polycystic ovary syndrome	0.000397	0.0138	CcSEcCtD
Epirubicin—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.000393	0.0137	CcSEcCtD
Epirubicin—Abdominal distension—Metformin—polycystic ovary syndrome	0.000382	0.0133	CcSEcCtD
Epirubicin—Influenza—Metformin—polycystic ovary syndrome	0.00038	0.0132	CcSEcCtD
Epirubicin—ABCC1—female gonad—polycystic ovary syndrome	0.000376	0.00682	CbGeAlD
Epirubicin—ABCC1—vagina—polycystic ovary syndrome	0.000374	0.00678	CbGeAlD
Epirubicin—Pancreatitis—Metformin—polycystic ovary syndrome	0.000372	0.013	CcSEcCtD
Epirubicin—Angina pectoris—Metformin—polycystic ovary syndrome	0.00037	0.0129	CcSEcCtD
Epirubicin—Neutropenia—Metformin—polycystic ovary syndrome	0.000355	0.0124	CcSEcCtD
Epirubicin—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.000353	0.0123	CcSEcCtD
Epirubicin—Doxorubicin—TOP2A—polycystic ovary syndrome	0.00035	0.0901	CrCbGaD
Epirubicin—Infestation NOS—Metformin—polycystic ovary syndrome	0.000339	0.0118	CcSEcCtD
Epirubicin—Infestation—Metformin—polycystic ovary syndrome	0.000339	0.0118	CcSEcCtD
Epirubicin—Drowsiness—Metformin—polycystic ovary syndrome	0.000339	0.0118	CcSEcCtD
Epirubicin—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.000332	0.0116	CcSEcCtD
Epirubicin—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00032	0.0112	CcSEcCtD
Epirubicin—Bradycardia—Metformin—polycystic ovary syndrome	0.000309	0.0108	CcSEcCtD
Epirubicin—Rhinitis—Metformin—polycystic ovary syndrome	0.000305	0.0106	CcSEcCtD
Epirubicin—Hepatitis—Metformin—polycystic ovary syndrome	0.000304	0.0106	CcSEcCtD
Epirubicin—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.000302	0.0105	CcSEcCtD
Epirubicin—Oedema peripheral—Metformin—polycystic ovary syndrome	0.000299	0.0104	CcSEcCtD
Epirubicin—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.000299	0.0104	CcSEcCtD
Epirubicin—Eye disorder—Metformin—polycystic ovary syndrome	0.000284	0.0099	CcSEcCtD
Epirubicin—Cardiac disorder—Metformin—polycystic ovary syndrome	0.000282	0.00984	CcSEcCtD
Epirubicin—Flushing—Metformin—polycystic ovary syndrome	0.000282	0.00984	CcSEcCtD
Epirubicin—Angiopathy—Metformin—polycystic ovary syndrome	0.000276	0.00962	CcSEcCtD
Epirubicin—Immune system disorder—Metformin—polycystic ovary syndrome	0.000275	0.00957	CcSEcCtD
Epirubicin—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.000274	0.00955	CcSEcCtD
Epirubicin—Chills—Metformin—polycystic ovary syndrome	0.000273	0.00951	CcSEcCtD
Epirubicin—Malnutrition—Metformin—polycystic ovary syndrome	0.000265	0.00923	CcSEcCtD
Epirubicin—Erythema—Metformin—polycystic ovary syndrome	0.000265	0.00923	CcSEcCtD
Epirubicin—Flatulence—Metformin—polycystic ovary syndrome	0.000261	0.00909	CcSEcCtD
Epirubicin—Dysgeusia—Metformin—polycystic ovary syndrome	0.000259	0.00903	CcSEcCtD
Epirubicin—Muscle spasms—Metformin—polycystic ovary syndrome	0.000254	0.00887	CcSEcCtD
Epirubicin—Vision blurred—Metformin—polycystic ovary syndrome	0.000249	0.0087	CcSEcCtD
Epirubicin—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000246	0.00856	CcSEcCtD
Epirubicin—Malaise—Metformin—polycystic ovary syndrome	0.000239	0.00832	CcSEcCtD
Epirubicin—Syncope—Metformin—polycystic ovary syndrome	0.000237	0.00827	CcSEcCtD
Epirubicin—Palpitations—Metformin—polycystic ovary syndrome	0.000234	0.00815	CcSEcCtD
Epirubicin—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000233	0.00811	CcSEcCtD
Epirubicin—Daunorubicin—CYP1A1—polycystic ovary syndrome	0.000231	0.0594	CrCbGaD
Epirubicin—Hypertension—Metformin—polycystic ovary syndrome	0.000228	0.00797	CcSEcCtD
Epirubicin—Chest pain—Metformin—polycystic ovary syndrome	0.000225	0.00785	CcSEcCtD
Epirubicin—Myalgia—Metformin—polycystic ovary syndrome	0.000225	0.00785	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000224	0.0078	CcSEcCtD
Epirubicin—Discomfort—Metformin—polycystic ovary syndrome	0.000223	0.00776	CcSEcCtD
Epirubicin—Oedema—Metformin—polycystic ovary syndrome	0.000216	0.00753	CcSEcCtD
Epirubicin—Infection—Metformin—polycystic ovary syndrome	0.000215	0.00748	CcSEcCtD
Epirubicin—Shock—Metformin—polycystic ovary syndrome	0.000212	0.00741	CcSEcCtD
Epirubicin—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000212	0.00738	CcSEcCtD
Epirubicin—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000211	0.00737	CcSEcCtD
Epirubicin—Skin disorder—Metformin—polycystic ovary syndrome	0.00021	0.00731	CcSEcCtD
Epirubicin—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000209	0.00728	CcSEcCtD
Epirubicin—Anorexia—Metformin—polycystic ovary syndrome	0.000206	0.00718	CcSEcCtD
Epirubicin—Hypotension—Metformin—polycystic ovary syndrome	0.000202	0.00704	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000197	0.00686	CcSEcCtD
Epirubicin—Paraesthesia—Metformin—polycystic ovary syndrome	0.000194	0.00676	CcSEcCtD
Epirubicin—Dyspnoea—Metformin—polycystic ovary syndrome	0.000193	0.00671	CcSEcCtD
Epirubicin—Somnolence—Metformin—polycystic ovary syndrome	0.000192	0.00669	CcSEcCtD
Epirubicin—Dyspepsia—Metformin—polycystic ovary syndrome	0.00019	0.00663	CcSEcCtD
Epirubicin—Decreased appetite—Metformin—polycystic ovary syndrome	0.000188	0.00655	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000186	0.0065	CcSEcCtD
Epirubicin—Fatigue—Metformin—polycystic ovary syndrome	0.000186	0.00649	CcSEcCtD
Epirubicin—Constipation—Metformin—polycystic ovary syndrome	0.000185	0.00644	CcSEcCtD
Epirubicin—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000178	0.0062	CcSEcCtD
Epirubicin—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000177	0.00616	CcSEcCtD
Epirubicin—Urticaria—Metformin—polycystic ovary syndrome	0.000172	0.00598	CcSEcCtD
Epirubicin—Abdominal pain—Metformin—polycystic ovary syndrome	0.000171	0.00595	CcSEcCtD
Epirubicin—Asthenia—Metformin—polycystic ovary syndrome	0.000155	0.0054	CcSEcCtD
Epirubicin—Pruritus—Metformin—polycystic ovary syndrome	0.000153	0.00533	CcSEcCtD
Epirubicin—Diarrhoea—Metformin—polycystic ovary syndrome	0.000148	0.00515	CcSEcCtD
Epirubicin—Dizziness—Metformin—polycystic ovary syndrome	0.000143	0.00498	CcSEcCtD
Epirubicin—Vomiting—Metformin—polycystic ovary syndrome	0.000137	0.00479	CcSEcCtD
Epirubicin—Rash—Metformin—polycystic ovary syndrome	0.000136	0.00475	CcSEcCtD
Epirubicin—Dermatitis—Metformin—polycystic ovary syndrome	0.000136	0.00474	CcSEcCtD
Epirubicin—Headache—Metformin—polycystic ovary syndrome	0.000135	0.00472	CcSEcCtD
Epirubicin—Nausea—Metformin—polycystic ovary syndrome	0.000128	0.00447	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	4.8e-05	0.000769	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	4.78e-05	0.000766	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—LMNA—polycystic ovary syndrome	4.75e-05	0.000762	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PTGER3—polycystic ovary syndrome	4.75e-05	0.000761	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—LHCGR—polycystic ovary syndrome	4.75e-05	0.000761	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—SUOX—polycystic ovary syndrome	4.69e-05	0.000751	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—LPCAT2—polycystic ovary syndrome	4.69e-05	0.000751	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	4.69e-05	0.000751	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—LPCAT2—polycystic ovary syndrome	4.6e-05	0.000737	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—AKR1C3—polycystic ovary syndrome	4.6e-05	0.000737	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—SUOX—polycystic ovary syndrome	4.6e-05	0.000737	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—MAD2L1—polycystic ovary syndrome	4.57e-05	0.000733	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	4.54e-05	0.000728	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—CYP17A1—polycystic ovary syndrome	4.53e-05	0.000725	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PTAFR—polycystic ovary syndrome	4.44e-05	0.000712	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—PPARG—polycystic ovary syndrome	4.4e-05	0.000706	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ISYNA1—polycystic ovary syndrome	4.36e-05	0.000699	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	4.35e-05	0.000697	CbGpPWpGaD
Epirubicin—UGT2B7—Biological oxidations—POMC—polycystic ovary syndrome	4.35e-05	0.000696	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	4.31e-05	0.000691	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ISYNA1—polycystic ovary syndrome	4.27e-05	0.000685	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—LMNA—polycystic ovary syndrome	4.25e-05	0.000681	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	4.2e-05	0.000673	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	4.19e-05	0.000672	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	4.18e-05	0.00067	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CCNB1—polycystic ovary syndrome	4.1e-05	0.000658	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—NMNAT3—polycystic ovary syndrome	4.02e-05	0.000644	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	3.97e-05	0.000636	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—TH—polycystic ovary syndrome	3.92e-05	0.000628	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	3.9e-05	0.000625	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FLT4—polycystic ovary syndrome	3.84e-05	0.000616	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	3.83e-05	0.000614	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PDE3B—polycystic ovary syndrome	3.82e-05	0.000612	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—SLC2A4—polycystic ovary syndrome	3.81e-05	0.000611	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	3.8e-05	0.000609	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	3.77e-05	0.000604	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	3.75e-05	0.0006	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—AKR1C2—polycystic ovary syndrome	3.71e-05	0.000594	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—TEAD2—polycystic ovary syndrome	3.71e-05	0.000594	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	3.7e-05	0.000593	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—LPCAT2—polycystic ovary syndrome	3.67e-05	0.000589	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SUOX—polycystic ovary syndrome	3.67e-05	0.000589	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CCNB1—polycystic ovary syndrome	3.67e-05	0.000588	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—AKR1C2—polycystic ovary syndrome	3.63e-05	0.000583	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—TEAD2—polycystic ovary syndrome	3.63e-05	0.000583	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	3.63e-05	0.000581	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—CYP19A1—polycystic ovary syndrome	3.58e-05	0.000574	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	3.49e-05	0.00056	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—PLAT—polycystic ovary syndrome	3.48e-05	0.000557	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—FSHR—polycystic ovary syndrome	3.48e-05	0.000557	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	3.44e-05	0.000551	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ISYNA1—polycystic ovary syndrome	3.42e-05	0.000547	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NPB—polycystic ovary syndrome	3.36e-05	0.000539	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—IGF1—polycystic ovary syndrome	3.35e-05	0.000538	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—AKT2—polycystic ovary syndrome	3.35e-05	0.000537	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	3.34e-05	0.000535	CbGpPWpGaD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—IL6—polycystic ovary syndrome	3.32e-05	0.000532	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	3.3e-05	0.00053	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	3.29e-05	0.000527	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—GNAS—polycystic ovary syndrome	3.2e-05	0.000512	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—SERPINE1—polycystic ovary syndrome	3.19e-05	0.00051	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	3.18e-05	0.000509	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	3.12e-05	0.000499	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PNPLA2—polycystic ovary syndrome	3.11e-05	0.000498	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—ADRB3—polycystic ovary syndrome	3.06e-05	0.00049	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—NCOR1—polycystic ovary syndrome	3.05e-05	0.000488	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PNPLA2—polycystic ovary syndrome	3.05e-05	0.000488	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	3.04e-05	0.000487	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—LHB—polycystic ovary syndrome	3.02e-05	0.000485	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	2.96e-05	0.000474	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—GNRH1—polycystic ovary syndrome	2.95e-05	0.000474	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—SRD5A1—polycystic ovary syndrome	2.94e-05	0.000472	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—TEAD2—polycystic ovary syndrome	2.9e-05	0.000465	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—AKR1C2—polycystic ovary syndrome	2.9e-05	0.000465	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—SRD5A1—polycystic ovary syndrome	2.89e-05	0.000463	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—CYP1A1—polycystic ovary syndrome	2.89e-05	0.000463	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	2.84e-05	0.000456	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—SCT—polycystic ovary syndrome	2.83e-05	0.000454	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—STAR—polycystic ovary syndrome	2.81e-05	0.00045	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PTGER3—polycystic ovary syndrome	2.8e-05	0.00045	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—LHCGR—polycystic ovary syndrome	2.8e-05	0.00045	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	2.79e-05	0.000448	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—STAR—polycystic ovary syndrome	2.75e-05	0.000441	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	2.75e-05	0.000441	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.72e-05	0.000436	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	2.7e-05	0.000433	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—MTHFR—polycystic ovary syndrome	2.69e-05	0.000431	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—GNAS—polycystic ovary syndrome	2.67e-05	0.000428	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PTAFR—polycystic ovary syndrome	2.62e-05	0.00042	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	2.59e-05	0.000415	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	2.55e-05	0.000408	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—HMMR—polycystic ovary syndrome	2.5e-05	0.000401	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	2.48e-05	0.000397	CbGpPWpGaD
Epirubicin—ABCC1—Disease—RPL37A—polycystic ovary syndrome	2.47e-05	0.000396	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	2.46e-05	0.000395	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—HMMR—polycystic ovary syndrome	2.46e-05	0.000393	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PNPLA2—polycystic ovary syndrome	2.43e-05	0.00039	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—INHBB—polycystic ovary syndrome	2.41e-05	0.000387	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	2.41e-05	0.000386	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—HSD3B1—polycystic ovary syndrome	2.39e-05	0.000383	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HMMR—polycystic ovary syndrome	2.34e-05	0.000375	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—HSD3B1—polycystic ovary syndrome	2.34e-05	0.000375	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.32e-05	0.000371	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SRD5A1—polycystic ovary syndrome	2.31e-05	0.00037	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PDE3B—polycystic ovary syndrome	2.25e-05	0.000361	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—STAR—polycystic ovary syndrome	2.2e-05	0.000353	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	2.2e-05	0.000353	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.19e-05	0.000352	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	2.19e-05	0.000351	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PPARG—polycystic ovary syndrome	2.18e-05	0.00035	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—LHB—polycystic ovary syndrome	2.18e-05	0.000349	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.18e-05	0.000349	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—POMC—polycystic ovary syndrome	2.15e-05	0.000345	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—INS—polycystic ovary syndrome	2.14e-05	0.000343	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—LHB—polycystic ovary syndrome	2.14e-05	0.000342	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—HSD3B2—polycystic ovary syndrome	2.13e-05	0.000341	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—HSD3B2—polycystic ovary syndrome	2.09e-05	0.000335	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—AKR1C1—polycystic ovary syndrome	2.06e-05	0.00033	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FSHR—polycystic ovary syndrome	2.05e-05	0.000329	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—AKR1C1—polycystic ovary syndrome	2.02e-05	0.000324	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—GHRL—polycystic ovary syndrome	2e-05	0.00032	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—HMMR—polycystic ovary syndrome	1.96e-05	0.000314	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	1.93e-05	0.000309	CbGpPWpGaD
Epirubicin—ABCC1—Disease—AKR1C1—polycystic ovary syndrome	1.93e-05	0.000309	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—SULT2A1—polycystic ovary syndrome	1.9e-05	0.000304	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—IL6—polycystic ovary syndrome	1.89e-05	0.000302	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	1.88e-05	0.000301	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—HSD3B1—polycystic ovary syndrome	1.87e-05	0.0003	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—SULT2A1—polycystic ovary syndrome	1.86e-05	0.000298	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.85e-05	0.000296	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.85e-05	0.000296	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—RRM2—polycystic ovary syndrome	1.84e-05	0.000295	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FST—polycystic ovary syndrome	1.83e-05	0.000293	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ADRB3—polycystic ovary syndrome	1.81e-05	0.00029	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—RRM2—polycystic ovary syndrome	1.8e-05	0.000289	CbGpPWpGaD
Epirubicin—ABCC1—Disease—FGF18—polycystic ovary syndrome	1.79e-05	0.000287	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—LHB—polycystic ovary syndrome	1.79e-05	0.000286	CbGpPWpGaD
Epirubicin—ABCC1—Disease—RBP4—polycystic ovary syndrome	1.78e-05	0.000285	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—YAP1—polycystic ovary syndrome	1.77e-05	0.000284	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.75e-05	0.000281	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GNRH1—polycystic ovary syndrome	1.75e-05	0.00028	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—YAP1—polycystic ovary syndrome	1.74e-05	0.000278	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—IGF1—polycystic ovary syndrome	1.73e-05	0.000277	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—AKT2—polycystic ovary syndrome	1.73e-05	0.000277	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—LHB—polycystic ovary syndrome	1.71e-05	0.000274	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—NAMPT—polycystic ovary syndrome	1.7e-05	0.000273	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	1.69e-05	0.000271	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CYP11A1—polycystic ovary syndrome	1.68e-05	0.000269	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SCT—polycystic ovary syndrome	1.67e-05	0.000268	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—NAMPT—polycystic ovary syndrome	1.67e-05	0.000267	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—HSD3B2—polycystic ovary syndrome	1.67e-05	0.000267	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.66e-05	0.000266	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	1.65e-05	0.000265	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CYP11A1—polycystic ovary syndrome	1.65e-05	0.000264	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—SERPINE1—polycystic ovary syndrome	1.64e-05	0.000263	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.64e-05	0.000262	CbGpPWpGaD
Epirubicin—ABCC1—Disease—GAB1—polycystic ovary syndrome	1.63e-05	0.000262	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—AKR1C1—polycystic ovary syndrome	1.62e-05	0.000259	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	1.6e-05	0.000256	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NAMPT—polycystic ovary syndrome	1.59e-05	0.000255	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—AKR1C3—polycystic ovary syndrome	1.59e-05	0.000254	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FGF18—polycystic ovary syndrome	1.57e-05	0.000251	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CYP17A1—polycystic ovary syndrome	1.56e-05	0.00025	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—AKR1C3—polycystic ovary syndrome	1.56e-05	0.000249	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RBP4—polycystic ovary syndrome	1.56e-05	0.000249	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CYP17A1—polycystic ovary syndrome	1.53e-05	0.000246	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—GNAS—polycystic ovary syndrome	1.53e-05	0.000246	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SULT2A1—polycystic ovary syndrome	1.49e-05	0.000238	CbGpPWpGaD
Epirubicin—ABCC1—Disease—AKR1C3—polycystic ovary syndrome	1.48e-05	0.000238	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TNRC6B—polycystic ovary syndrome	1.46e-05	0.000234	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—YAP1—polycystic ovary syndrome	1.45e-05	0.000233	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—RRM2—polycystic ovary syndrome	1.44e-05	0.000231	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GAB1—polycystic ovary syndrome	1.43e-05	0.00023	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—YAP1—polycystic ovary syndrome	1.39e-05	0.000222	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—INSR—polycystic ovary syndrome	1.37e-05	0.00022	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—TH—polycystic ovary syndrome	1.35e-05	0.000217	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—NAMPT—polycystic ovary syndrome	1.33e-05	0.000214	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—TH—polycystic ovary syndrome	1.33e-05	0.000212	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.33e-05	0.000212	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP11A1—polycystic ovary syndrome	1.32e-05	0.000211	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—SLC2A4—polycystic ovary syndrome	1.32e-05	0.000211	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.31e-05	0.00021	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.3e-05	0.000209	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—SLC2A4—polycystic ovary syndrome	1.29e-05	0.000207	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.28e-05	0.000205	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PGR—polycystic ovary syndrome	1.27e-05	0.000203	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TCF7L2—polycystic ovary syndrome	1.25e-05	0.000201	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—AKR1C3—polycystic ovary syndrome	1.24e-05	0.000199	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CYP19A1—polycystic ovary syndrome	1.24e-05	0.000198	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SLC2A4—polycystic ovary syndrome	1.23e-05	0.000197	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP17A1—polycystic ovary syndrome	1.22e-05	0.000196	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CYP19A1—polycystic ovary syndrome	1.21e-05	0.000194	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GHRL—polycystic ovary syndrome	1.18e-05	0.000189	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PLAT—polycystic ovary syndrome	1.18e-05	0.000189	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PRL—polycystic ovary syndrome	1.17e-05	0.000188	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—VEGFA—polycystic ovary syndrome	1.13e-05	0.000181	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ATF1—polycystic ovary syndrome	1.12e-05	0.00018	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GNAS—polycystic ovary syndrome	1.1e-05	0.000177	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.1e-05	0.000176	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GNAS—polycystic ovary syndrome	1.08e-05	0.000173	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—TH—polycystic ovary syndrome	1.06e-05	0.00017	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—NCOR1—polycystic ovary syndrome	1.05e-05	0.000169	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NGFR—polycystic ovary syndrome	1.04e-05	0.000166	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—POMC—polycystic ovary syndrome	1.03e-05	0.000165	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—NCOR1—polycystic ovary syndrome	1.03e-05	0.000165	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SLC2A4—polycystic ovary syndrome	1.03e-05	0.000165	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PRL—polycystic ovary syndrome	1.03e-05	0.000165	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CYP1A1—polycystic ovary syndrome	9.97e-06	0.00016	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—AKT2—polycystic ovary syndrome	9.92e-06	0.000159	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NCOR1—polycystic ovary syndrome	9.84e-06	0.000158	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CYP1A1—polycystic ovary syndrome	9.77e-06	0.000157	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ADRB2—polycystic ovary syndrome	9.76e-06	0.000156	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP19A1—polycystic ovary syndrome	9.69e-06	0.000155	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NRG1—polycystic ovary syndrome	9.66e-06	0.000155	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—MTHFR—polycystic ovary syndrome	9.29e-06	0.000149	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—MTHFR—polycystic ovary syndrome	9.11e-06	0.000146	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GNAS—polycystic ovary syndrome	9.05e-06	0.000145	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MTHFR—polycystic ovary syndrome	8.69e-06	0.000139	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GNAS—polycystic ovary syndrome	8.65e-06	0.000139	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.62e-06	0.000138	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NRG1—polycystic ovary syndrome	8.46e-06	0.000136	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IRS2—polycystic ovary syndrome	8.27e-06	0.000133	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—NCOR1—polycystic ovary syndrome	8.24e-06	0.000132	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP1A1—polycystic ovary syndrome	7.81e-06	0.000125	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PPARG—polycystic ovary syndrome	7.53e-06	0.000121	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—POMC—polycystic ovary syndrome	7.43e-06	0.000119	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—INS—polycystic ovary syndrome	7.39e-06	0.000118	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PPARG—polycystic ovary syndrome	7.39e-06	0.000118	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—POMC—polycystic ovary syndrome	7.29e-06	0.000117	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—MTHFR—polycystic ovary syndrome	7.28e-06	0.000117	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IRS2—polycystic ovary syndrome	7.25e-06	0.000116	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—INS—polycystic ovary syndrome	7.25e-06	0.000116	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IRS1—polycystic ovary syndrome	7.22e-06	0.000116	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—LEP—polycystic ovary syndrome	7.09e-06	0.000114	CbGpPWpGaD
Epirubicin—ABCC1—Disease—INS—polycystic ovary syndrome	6.91e-06	0.000111	CbGpPWpGaD
Epirubicin—ABCC1—Disease—AKT2—polycystic ovary syndrome	6.68e-06	0.000107	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SERPINE1—polycystic ovary syndrome	6.35e-06	0.000102	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IRS1—polycystic ovary syndrome	6.33e-06	0.000101	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—POMC—polycystic ovary syndrome	6.09e-06	9.77e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—INS—polycystic ovary syndrome	6.06e-06	9.71e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PPARG—polycystic ovary syndrome	5.9e-06	9.46e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IGF1—polycystic ovary syndrome	5.86e-06	9.39e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AKT2—polycystic ovary syndrome	5.86e-06	9.39e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—POMC—polycystic ovary syndrome	5.82e-06	9.33e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—INS—polycystic ovary syndrome	5.79e-06	9.28e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.57e-06	8.92e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL6—polycystic ovary syndrome	4.48e-06	7.18e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.83e-06	6.14e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IL6—polycystic ovary syndrome	3.02e-06	4.84e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL6—polycystic ovary syndrome	2.65e-06	4.24e-05	CbGpPWpGaD
